NCT00195208View on ClinicalTrials.gov

Study Comparing a Pantoprazole Formulation to the Currently Marketed Tablet for GERD and Erosive Esophagitis

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

November 30, 2005

Study Completion Date

November 30, 2005

Conditions

Gastroesophageal RefluxEsophagitis

Interventions

DRUG

Pantoprazole for approximately 9 weeks

Trial Locations (9)

19104

Philadelphia

19140

Philadelphia

33173

Miami

73104

Oklahoma City

73112

Oklahoma City

90073

Los Angeles

92103

San Diego

92801

Anaheim

92869

Orange

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00195208 - Study Comparing a Pantoprazole Formulation to the Currently Marketed Tablet for GERD and Erosive Esophagitis | Biotech Hunter | Biotech Hunter